NovaRadar Bio Sustainability Fund I Officially Launched

NovaRadar Bio Venture Corporation announced the official launch of its first fund, the "NovaRadar Bio Sustainability Fund I." The fund successfully raised NT$3 billion, with a strategic focus on two key areas: next-generation nucleic acid therapeutics and AI-driven precision screening. The fund will continue to uphold the company's guiding philosophy of "scientific rigor, protecting life, sustainable co-prosperity," targeting globally competitive biotech and healthcare investment opportunities.